Tekla Capital Management LLC Ptc Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $5.49 Million - $6.9 Million	-120,827 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $695,955 - $1.28 Million	21,500 Added 21.65%	120,827 $5.39 Million
Q4 2019 Feb 13, 2020	SELL	$32.22 - $50.07 $1.58 Million - $2.46 Million	-49,108 Reduced 33.08%	99,327 $4.77 Million
Q3 2019 Nov 13, 2019	BUY	$33.82 - $48.17 $298,529 - $425,196	8,827 Added 6.32%	148,435 $5.02 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $2.51 Million - $3.19 Million	70,956 Added 103.36%	139,608 $6.28 Million
Q4 2018 Feb 13, 2019	BUY	$29.83 - $46.51 $604,415 - $942,385	20,262 Added 41.87%	68,652 $2.36 Million
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $1.64 Million - $2.31 Million	48,390 New	48,390 $2.27 Million
Q2 2018 Aug 13, 2018	SELL	$25.7 - $47.88 $624,484 - $1.16 Million	-24,299 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$17.46 - $32.59 $424,260 - $791,904	24,299 New	24,299 $658,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.